Orell Fuessli Aktie 342080 / CH0003420806
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
11.11.2025 07:00:03
|
Orell Füssli Presents Strategic Priorities until 2028
|
Orell Füssli AG
/ Key word(s): Miscellaneous
Orell Füssli Presents Strategic Priorities until 2028 Zurich, 11 November 2025 – At today's Capital Markets Day, Orell Füssli provides insights into its business areas and presents its strategic priorities for the second half of the strategy cycle until 2028. There is a particular focus on expanding activities in the growing market for digital identities and credentials. The company confirms its ambitious targets of achieving revenue of CHF 300 million and an EBIT margin of at least 8% by 2028. It also continues to aim to distribute 60 to 80% of net profit as dividends. Successful implementation of the growth strategy Since launching its growth strategy in 2022, Orell Füssli has recorded an encouraging development: by the end of 2024, sales had risen by 16% and EBIT by 52% – exceeding the target range. Thanks to a diversified and resilient business model, the company is well positioned to take advantage of opportunities in existing and new markets. The core business in the areas of security printing and book retailing is characterised by stable returns and strong cash generation. Zeiser and the publishing houses are successfully positioned in profitable niches. At the same time, the dynamically growing market for digital identities, credentials and wallets is opening up attractive opportunities for sustainable value creation. Results to date confirm that Orell Füssli is on track to achieve its growth targets for the strategy period up to 2028. At mid-year 2025, the company raised its guidance for the full year and now expects revenue growth above the target range of 4 - 6% and an EBIT margin slightly above the previous year's level. Developments in society strengthen Orell Füssli's position Key social trends underscore the growing need to protect tangible and intangible assets and prevent the misuse of identities and private data. Global demand for banknotes continues to rise. At the same time, the education market is gaining momentum, driven by increased interest in lifelong learning, new commercial providers and digital learning solutions. Digital identities, credentials and wallets are becoming an important topic for the future with great international potential. In Europe, the eIDAS 2.0 regulation is providing additional momentum, as all 27 EU member states must implement it by the end of 2026. As a system provider for security printing and identification solutions, market leader in brick-and-mortar and online book retailing, and a major provider of Swiss learning media, Orell Füssli is ideally positioned to take advantage of these developments. Targeted measures for the second half of the strategy period until 2028 Until 2028, Orell Füssli will focus on profitable growth, expanding its market positions and further developing its digital offerings. At the same time, the company will set clear priorities in the areas of innovation, sustainability and employer attractiveness. Security printing and Zeiser: introduction of new innovations, ensuring high production capacity utilisation and targeted expansion of international business with security documents and track & trace software solutions from Zeiser. Book retail: Expansion of the branch network and further strengthening of market leadership in brick-and-mortar and online business with B2B and B2C customers. Publishing: Leveraging synergies by integrating the back offices and IT areas of the various publishing houses and expanding the digital learning offering. The strategic focus will be expanded beyond traditional learning media in order to strengthen the education portfolio as a whole. Procivis: Establishing a strong national and international position as a provider of software solutions for digital identities and credentials. Based on the new technology platform Procivis One, collaborations with public authorities and businesses are to be expanded, thereby laying the foundation for further growth. Daniel Link, CEO of Orell Füssli:
Agenda Publication of Annual Report 18 March 2026 Contact us Orell Füssli Ltd
Additional features: File: MR-OF_CMD_2025_EN
End of Media Release |
| Language: | English |
| Company: | Orell Füssli AG |
| Dietzingerstrasse 3 | |
| 8003 Zürich | |
| Switzerland | |
| Fax: | 044 466 77 11 |
| E-mail: | info@orellfuessli.com |
| Internet: | https://www.orellfuessli.com/ |
| ISIN: | CH0003420806 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2227266 |
| End of News | EQS News Service |
|
|
2227266 11.11.2025 CET/CEST
Nachrichten zu Orell Fuessli AG
Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest
Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.
Schnell noch Plätze sichern!Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI letztlich fester -- DAX schliesslich freundlich -- Märkte in Fernost enden uneinheitlichSowohl der heimische als auch der deutsche Aktienmarkt präsentierten sich am Dienstag fester. Der US-Aktienmarkt bewegt sich am Dienstag in unterschiedliche Richtungen. Die wichtigsten asiatischen Börsen zeigten sich am Dienstag uneins.


